{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:01:57Z","timestamp":1792789317957,"version":"4.5.0"},"reference-count":109,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is the most common endocrine-metabolic disease in females of reproductive age, affecting 4\u201320% of pre-menopausal women worldwide. MicroRNAs (miRNAs) are endogenous, single-stranded, non-coding, regulatory ribonucleic acid molecules found in eukaryotic cells. Abnormal miRNA expression has been associated with several diseases and could possibly explain their underlying pathophysiology. MiRNAs have been extensively studied for their potential diagnostic, prognostic, and therapeutic uses in many diseases, such as type 2 diabetes, obesity, cardiovascular disease, PCOS, and endometriosis. In women with PCOS, miRNAs were found to be abnormally expressed in theca cells, follicular fluid, granulosa cells, peripheral blood leukocytes, serum, and adipose tissue when compared to those without PCOS, making miRNAs a useful potential biomarker for the disease. Key pathways involved in PCOS, such as folliculogenesis, steroidogenesis, and cellular adhesion, are regulated by miRNA. This also highlights their importance as potential prognostic markers. In addition, recent evidence suggests a role for miRNAs in regulating the circadian rhythm (CR). CR is crucial for regulating reproduction through the various functions of the hypothalamic-pituitary-gonadal (HPG) axis and the ovaries. A disordered CR affects reproductive outcomes by inducing insulin resistance, oxidative stress, and systemic inflammation. Moreover, miRNAs were demonstrated to interact with lncRNA and circRNAs, which are thought to play a role in the pathogenesis of PCOS. This review discusses what is currently understood about miRNAs in PCOS, the cellular pathways involved, and their potential role as biomarkers and therapeutic targets.<\/jats:p>","DOI":"10.3390\/ijms25020903","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T06:52:14Z","timestamp":1704955934000},"page":"903","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review"],"prefix":"10.3390","volume":"25","author":[{"given":"Jenan Sh.","family":"Nasser","sequence":"first","affiliation":[{"name":"School of Medicine, Royal College of Surgeons of Ireland, Busaiteen, Adliya 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Altahoo","sequence":"additional","affiliation":[{"name":"School of Medicine, Royal College of Surgeons of Ireland, Busaiteen, Adliya 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9207-7405","authenticated-orcid":false,"given":"Sayed","family":"Almosawi","sequence":"additional","affiliation":[{"name":"School of Medicine, Royal College of Surgeons of Ireland, Busaiteen, Adliya 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar","family":"Alhermi","sequence":"additional","affiliation":[{"name":"School of Medicine, Royal College of Surgeons of Ireland, Busaiteen, Adliya 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[{"name":"Research Department, Royal College of Surgeons of Ireland, Busaiteen, Adliya 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic Ovary Syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment","volume":"14","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review","volume":"13","author":"Deswal","year":"2020","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment with Emphasis on Adolescent Girls","volume":"3","author":"Witchel","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"33","author":"Randeva","year":"2012","journal-title":"Endocr. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2005-1494","article-title":"Heritability of polycystic ovary syndrome in a Dutch twin-family study","volume":"91","author":"Vink","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/er.2004-0004","article-title":"The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome","volume":"26","year":"2005","journal-title":"Endocr. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/emph\/eoz011","article-title":"Evolutionary origins of polycystic ovary syndrome: An environmental mismatch disorder","volume":"2019","author":"Charifson","year":"2019","journal-title":"Evol. Med. Public Health"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil. Steril."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajum.12096","article-title":"Rotterdam criteria, the end","volume":"21","author":"Smet","year":"2018","journal-title":"Australas. J. Ultrasound Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: Consequences, Challenges, and Guiding Treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil. Steril."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/0973-029X.140762","article-title":"MicroRNAs\u2014Biology and clinical applications","volume":"18","author":"Ranganathan","year":"2014","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.molcel.2016.09.004","article-title":"Pairing beyond the Seed Supports MicroRNA Targeting Specificity","volume":"64","author":"Broughton","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"Hayder","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0300985813502820","article-title":"MicroRNAs: History, biogenesis, and their evolving role in animal development and disease","volume":"51","author":"Bhaskaran","year":"2014","journal-title":"Vet. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.acc.2015.06.001","article-title":"Polycystic ovary syndrome-epigenetic mechanisms and aberrant microRNA","volume":"71","author":"Ilie","year":"2015","journal-title":"Adv. Clin. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"118174","DOI":"10.1016\/j.lfs.2020.118174","article-title":"miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review","volume":"259","author":"Abdalla","year":"2020","journal-title":"Life Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nrg2455","article-title":"Biological principles of microRNA-mediated regulation: Shared themes amid diversity","volume":"9","author":"Flynt","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1002\/jcb.26531","article-title":"Identification of microRNAs and genes associated with hyperandrogenism in the follicular fluid of women with polycystic ovary syndrome","volume":"119","author":"Xue","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Vitale, S.G., Fulghesu, A.M., Mikus, M., Watrowski, R., D\u2019Alterio, M.N., Lin, L.T., Shah, M., Reyes-Mu\u00f1oz, E., Sathyapalan, T., and Angioni, S. (2022). The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside\u2014A Systematic Literature Review. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081816"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.fertnstert.2014.04.024","article-title":"Regulatory role of microRNAs in ovarian function","volume":"101","author":"Imbar","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14348\/molcells.2023.2157","article-title":"Determinants of Functional MicroRNA Targeting","volume":"46","author":"Hwang","year":"2023","journal-title":"Mol. Cells"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ho, P.T.B., Clark, I.M., and Le, L.T.T. (2022). MicroRNA-Based Diagnosis and Therapy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137167"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.fertnstert.2017.11.036","article-title":"Micro-RNA profile and proteins in peritoneal fluid from women with endometriosis: Their relationship with sterility","volume":"109","author":"Estelles","year":"2018","journal-title":"Fertil. Steril."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","article-title":"MicroRNAs in body fluids\u2014The mix of hormones and biomarkers","volume":"8","author":"Cortez","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_29","first-page":"5785","article-title":"miR-339-5p inhibits lung adenocarcinoma invasion and migration by directly targeting BCL6","volume":"16","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1007\/s13277-015-4390-2","article-title":"miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6","volume":"37","author":"Shan","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"16890","DOI":"10.1038\/srep16890","article-title":"Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis","volume":"5","author":"Sathyapalan","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"17442","DOI":"10.1074\/jbc.M110.107821","article-title":"Secretory mechanisms and intercellular transfer of microRNAs in living cells","volume":"285","author":"Kosaka","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gene.2019.04.082","article-title":"The role of MiRNA in polycystic ovary syndrome (PCOS)","volume":"706","author":"Chen","year":"2019","journal-title":"Gene"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.tjog.2022.05.013","article-title":"Characterization of altered microRNAs related to different phenotypes of polycystic ovarian syndrome (PCOS) in serum, follicular fluid, and cumulus cells","volume":"61","author":"Mowla","year":"2022","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.glohj.2022.03.002","article-title":"Management strategy of infertility in polycystic ovary syndrome","volume":"6","author":"Li","year":"2022","journal-title":"Glob. Health J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.21037\/atm-22-714","article-title":"The relationship between polycystic ovary syndrome and infertility: A bibliometric analysis","volume":"10","author":"Zhuang","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1179558119890867","DOI":"10.1177\/1179558119890867","article-title":"Fertility Treatment Options for Women with Polycystic Ovary Syndrome","volume":"13","author":"Sawant","year":"2019","journal-title":"Clin. Med. Insights Reprod. Health"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/13697137.2017.1316256","article-title":"Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?","volume":"20","author":"Gunning","year":"2017","journal-title":"Climacteric"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"16306","DOI":"10.1038\/s41598-019-52856-5","article-title":"Expression of microRNA in follicular fluid in women with and without PCOS","volume":"9","author":"Butler","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9240569","DOI":"10.1155\/2022\/9240569","article-title":"Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature","volume":"2022","author":"Xu","year":"2022","journal-title":"J. Healthc. Eng."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10815-013-0161-4","article-title":"Altered microRNA and gene expression in the follicular fluid of women with polycystic ovary syndrome","volume":"31","author":"Roth","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"14671","DOI":"10.1038\/s41598-017-13250-1","article-title":"Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes","volume":"7","author":"Naji","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.gene.2018.10.006","article-title":"miR-323-3p regulates the steroidogenesis and cell apoptosis in polycystic ovary syndrome (PCOS) by targeting IGF-1","volume":"683","author":"Wang","year":"2019","journal-title":"Gene"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.bbrc.2016.12.059","article-title":"Deregulation of RUNX2 by miR-320a deficiency impairs steroidogenesis in cumulus granulosa cells from polycystic ovary syndrome (PCOS) patients","volume":"482","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/0366-6999.149189","article-title":"Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance","volume":"128","author":"Lin","year":"2015","journal-title":"Chin. Med. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","article-title":"Insulin resistance in polycystic ovary syndrome across various tissues: An updated review of pathogenesis, evaluation, and treatment","volume":"16","author":"Zhao","year":"2023","journal-title":"J. Ovarian Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2337\/db12-0963","article-title":"miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance","volume":"62","author":"Chen","year":"2013","journal-title":"Diabetes"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11010-011-0727-3","article-title":"Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes","volume":"351","author":"Balasubramanyam","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mce.2013.04.019","article-title":"Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin","volume":"374","author":"Coleman","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fendo.2018.00719","article-title":"Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs","volume":"9","author":"Capuani","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"104662","DOI":"10.1016\/j.phrs.2020.104662","article-title":"Incretins and microRNAs: Interactions and physiological relevance","volume":"153","author":"Radbakhsh","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/09513590.2010.492886","article-title":"The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome","volume":"27","author":"Angioni","year":"2011","journal-title":"Gynecol. Endocrinol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12964-022-00876-6","article-title":"Follicular fluid-derived exosomal miR-143-3p\/miR-155-5p regulate follicular dysplasia by modulating glycolysis in granulosa cells in polycystic ovary syndrome","volume":"20","author":"Cao","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1158\/1940-6207.CAPR-11-0299","article-title":"Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells","volume":"5","author":"Bao","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: A \u201crisk-enhancing\u201d factor for cardiovascular disease","volume":"117","author":"Guan","year":"2022","journal-title":"Fertil. Steril."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cen.14117","article-title":"The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome","volume":"92","author":"Meun","year":"2020","journal-title":"Clin. Endocrinol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","article-title":"Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention","volume":"30","author":"Osibogun","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.fertnstert.2022.02.028","article-title":"Subclinical cardiovascular disease and polycystic ovary syndrome","volume":"117","author":"Gomez","year":"2022","journal-title":"Fertil. Steril."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"614679","DOI":"10.3389\/fendo.2021.614679","article-title":"Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women with Polycystic Ovary Syndrome","volume":"12","author":"Duica","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1124\/jpet.121.001152","article-title":"The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments","volume":"384","author":"Wronska","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.rbmo.2021.09.017","article-title":"The role of miRNA-339-5p in the function of vascular endothelial progenitor cells in patients with PCOS","volume":"44","author":"Zhang","year":"2022","journal-title":"Reprod. Biomed. Online"},{"key":"ref_62","first-page":"208","article-title":"Endothelial progenitor cell dysfunction in polycystic ovary syndrome: Implications for the genesis of cardiovascular diseases","volume":"6","author":"Kao","year":"2013","journal-title":"Int. J. Fertil. Steril."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/GCO.0000000000000554","article-title":"Sleep and female reproduction","volume":"31","author":"Willis","year":"2019","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"918805","DOI":"10.3389\/fendo.2022.918805","article-title":"Therapeutic potential of exosomes\/miRNAs in polycystic ovary syndrome induced by the alteration of circadian rhythms","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"25925","DOI":"10.1074\/jbc.M114.567628","article-title":"Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling","volume":"289","author":"Zhang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"bqab117","DOI":"10.1210\/endocr\/bqab117","article-title":"Circadian Rhythms within the Female HPG Axis: From Physiology to Etiology","volume":"162","author":"Shao","year":"2021","journal-title":"Endocrinology"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Das, M., Mohanty, S.R., Minocha, T., Mishra, N.K., Yadav, S.K., and Haldar, C. (2022). Circadian desynchronization in pregnancy of Golden hamster following long time light exposure: Involvement of Akt\/FoxO1 pathway. J. Photochem. Photobiol. B, 234.","DOI":"10.1016\/j.jphotobiol.2022.112508"},{"key":"ref_68","first-page":"13","article-title":"Circulating Mir-132, Mir-146a, Mir-222, and Mir-320 Expression in Differential Diagnosis of Women with Polycystic Ovary Syndrome","volume":"18","author":"Soyman","year":"2022","journal-title":"Acta Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/jc.2018-00544","article-title":"The HMGA2-IMP2 Pathway Promotes Granulosa Cell Proliferation in Polycystic Ovary Syndrome","volume":"104","author":"Li","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3389\/fphys.2020.00904","article-title":"Circulating and Adipose Tissue miRNAs in Women with Polycystic Ovary Syndrome and Responses to High-Intensity Interval Training","volume":"11","author":"Lionett","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/21691401.2019.1699826","article-title":"miR-155 is high-expressed in polycystic ovarian syndrome and promotes cell proliferation and migration through targeting PDCD4 in KGN cells","volume":"48","author":"Xia","year":"2020","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/humrep\/dead043","article-title":"Validation of circulating microRNAs miR-142-3p and miR-598-3p in women with polycystic ovary syndrome as potential diagnostic markers","volume":"38","author":"Insenser","year":"2023","journal-title":"Hum. Reprod."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"E8855","DOI":"10.1073\/pnas.1706611114","article-title":"Period2 3\u2032-UTR and microRNA-24 regulate circadian rhythms by repressing PERIOD2 protein accumulation","volume":"114","author":"Yoo","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12020-016-0878-9","article-title":"Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome","volume":"53","author":"Jiang","year":"2016","journal-title":"Endocrine"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e2020454118","DOI":"10.1073\/pnas.2020454118","article-title":"A genome-wide microRNA screen identifies the microRNA-183\/96\/182 cluster as a modulator of circadian rhythms","volume":"118","author":"Zhou","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2022.12.007","article-title":"The molecular mechanism of miR-96-5p in the pathogenesis and treatment of polycystic ovary syndrome","volume":"256","author":"Liu","year":"2023","journal-title":"Transl. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1210\/jc.2015-3588","article-title":"MicroRNA Species in Follicular Fluid Associating with Polycystic Ovary Syndrome and Related Intermediary Phenotypes","volume":"101","author":"Sorensen","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00404-020-05730-z","article-title":"MiRNAs expression profiling of rat ovaries displaying PCOS with insulin resistance","volume":"302","author":"Zhang","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.7150\/ijbs.26518","article-title":"Extracellular Vesicles: Potential Participants in Circadian Rhythm Synchronization","volume":"14","author":"Tao","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Chen, L., Zhang, B., Yang, L., Bai, Y.G., Song, J.B., Ge, Y.L., Ma, H.Z., Cheng, J.H., Ma, J., and Xie, M.J. (2019). BMAL1 Disrupted Intrinsic Diurnal Oscillation in Rat Cerebrovascular Contractility of Simulated Microgravity Rats by Altering Circadian Regulation of miR-103\/Ca(V)1.2 Signal Pathway. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163947"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes","volume":"107","author":"Zampetaki","year":"2010","journal-title":"Circ. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/genes5030684","article-title":"MicroRNAs Related to Polycystic Ovary Syndrome (PCOS)","volume":"5","author":"Sorensen","year":"2014","journal-title":"Genes"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1159\/000358698","article-title":"Characterization of serum microRNAs profile of PCOS and identification of novel non-invasive biomarkers","volume":"33","author":"Long","year":"2014","journal-title":"Cell Physiol. Biochem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2019.11.001","article-title":"Dissecting the role of micro-RNAs as a diagnostic marker for polycystic ovary syndrome: A systematic review and meta-analysis","volume":"113","author":"Deswal","year":"2020","journal-title":"Fertil. Steril."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"De Nardo Maffazioli, G., Baracat, E.C., Soares, J.M., Carvalho, K.C., and Maciel, G.A.R. (2022). Evaluation of circulating microRNA profiles in Brazilian women with polycystic ovary syndrome: A preliminary study. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0275031"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1080\/09513590.2018.1428299","article-title":"Serum miRNAs in women affected by hyperandrogenic polycystic ovary syndrome: The potential role of miR-155 as a biomarker for monitoring the estroprogestinic treatment","volume":"34","author":"Arancio","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.fertnstert.2020.08.019","article-title":"Differential expression profile of plasma exosomal microRNAs in women with polycystic ovary syndrome","volume":"115","author":"Jiang","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Udesen, P.B., Sorensen, A.E., Svendsen, R., Frisk, N.L.S., Hess, A.L., Aziz, M., Wissing, M.L.M., Englund, A.L.M., and Dalgaard, L.T. (2023). Circulating miRNAs in Women with Polycystic Ovary Syndrome: A Longitudinal Cohort Study. Cells, 12.","DOI":"10.3390\/cells12070983"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/molehr\/gaz014","article-title":"Dysregulated miR-142, -33b and -423 in granulosa cells target TGFBR1 and SMAD7: A possible role in polycystic ovary syndrome","volume":"25","author":"Li","year":"2019","journal-title":"Mol. Hum. Reprod."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/jcmm.17139","article-title":"microRNAs and long non-coding RNAs as biomarkers for polycystic ovary syndrome","volume":"26","author":"Tamaddon","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/cen.14087","article-title":"Alterations in long noncoding RNAs in women with and without polycystic ovarian syndrome","volume":"91","author":"Butler","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.csbj.2021.04.062","article-title":"Interplay between miRNAs and lncRNAs: Mode of action and biological roles in plant development and stress adaptation","volume":"19","author":"Meng","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","article-title":"MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside","volume":"15","author":"Ratti","year":"2020","journal-title":"Target. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.omtn.2020.12.008","article-title":"Long non-coding RNA lnc-CCNL1-3:1 promotes granulosa cell apoptosis and suppresses glucose uptake in women with polycystic ovary syndrome","volume":"23","author":"Huang","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_95","first-page":"1581","article-title":"LncRNA BANCR participates in polycystic ovary syndrome by promoting cell apoptosis","volume":"19","author":"Yang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1016\/j.ygeno.2020.04.011","article-title":"Downregulation of lncRNA ZFAS1 and upregulation of microRNA-129 repress endocrine disturbance, increase proliferation and inhibit apoptosis of ovarian granulosa cells in polycystic ovarian syndrome by downregulating HMGB1","volume":"112","author":"Zhu","year":"2020","journal-title":"Genomics"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/febs.16678","article-title":"Regulatory mechanisms of HMGB1 and its receptors in polycystic ovary syndrome-driven gravid uterine inflammation","volume":"290","author":"Hu","year":"2023","journal-title":"FEBS J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ncrna.2023.02.008","article-title":"LncRNA NEAT1 and MALAT1 are involved in polycystic ovary syndrome pathogenesis by functioning as competing endogenous RNAs to control the expression of PCOS-related target genes","volume":"8","author":"ElMonier","year":"2023","journal-title":"Noncoding RNA Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/jcmm.14753","article-title":"Down-regulated lncRNA HOTAIR alleviates polycystic ovaries syndrome in rats by reducing expression of insulin-like growth factor 1 via microRNA-130a","volume":"24","author":"Jiang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"110697","DOI":"10.1016\/j.mce.2019.110697","article-title":"LncRNA HCP5 promotes cell proliferation and inhibits apoptosis via miR-27a-3p\/IGF-1 axis in human granulosa-like tumor cell line KGN","volume":"503","author":"Chen","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1080\/21655979.2021.1964157","article-title":"Circular RNA circ_RANBP9 exacerbates polycystic ovary syndrome via microRNA-136-5p\/XIAP axis","volume":"12","author":"Lu","year":"2021","journal-title":"Bioengineered"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1111\/jcmm.15747","article-title":"CircPSMC3 alleviates the symptoms of PCOS by sponging miR-296-3p and regulating PTEN expression","volume":"24","author":"Liu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.21037\/atm-21-4174","article-title":"Involvement of ferroptosis in the granulosa cells proliferation of PCOS through the circRHBG\/miR-515\/SLC7A11 axis","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13048-021-00891-0","article-title":"Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p\/BCL2 axis","volume":"14","author":"Chen","year":"2021","journal-title":"J. Ovarian Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"144903","DOI":"10.1016\/j.gene.2020.144903","article-title":"circPUM1 promotes polycystic ovary syndrome progression by sponging to miR-760","volume":"754","author":"Deng","year":"2020","journal-title":"Gene"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/jcmm.16231","article-title":"CircASPH promotes KGN cells proliferation through miR-375\/MAP2K6 axis in Polycystic Ovary Syndrome","volume":"26","author":"Wu","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Xu, L., Xiong, F., Bai, Y., Xiao, J., Zhang, Y., Chen, J., and Li, Q. (2021). Circ_0043532 regulates miR-182\/SGK3 axis to promote granulosa cell progression in polycystic ovary syndrome. Reprod. Biol. Endocrinol., 19.","DOI":"10.1186\/s12958-021-00839-5"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"689916","DOI":"10.3389\/fgene.2021.689916","article-title":"SNAI2-Induced CircMTO1 Promotes Cell Proliferation and Inhibits Apoptosis Through the miR-320b\/MCL1 Axis in Human Granulosa-Like Tumor Cells","volume":"12","author":"Duan","year":"2021","journal-title":"Front. Genet."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1080\/21655979.2022.2041796","article-title":"The circular RNA circ_0030018\/miR-136\/migration and invasion enhancer 1 (MIEN1) axis promotes the progression of polycystic ovary syndrome","volume":"13","author":"Xu","year":"2022","journal-title":"Bioengineered"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/903\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:44:16Z","timestamp":1760103856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":109,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25020903"],"URL":"https:\/\/doi.org\/10.3390\/ijms25020903","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]}}}